HRTX: the cash flow

Cash Flow Overview

Change in Cash

$26,552K

Free Cash flow

$1,331K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-09-30

2025-06-30

Net loss

-17,241

Loss on disposal of property and equipment

-95

Stock-based compensation expense

2,852

5,308

Depreciation and amortization

615

1,162

Amortization of debt discount

194

311

Amortization of debt issuance costs

106

Accretion of discount on short-term investments

130

520

Retirement and impairment of property and equipment

409

Loss on extinguishment of debt

-11,339

Accounts receivable

1,116

1,050

Net loss

254

Inventory

-2,940

19,805

Prepaid expenses and other assets

5,248

-698

Accounts payable

-20

328

Accrued clinical and manufacturing liabilities

2,296

-8,083

Accrued payroll and employee related liabilities

2,277

-3,083

Other accrued expenses

2,511

4,541

Net cash used in operating activities

1,331

-19,738

Purchases of short-term investments

6,127

32,087

Maturities and sales of short-term investments

17,956

41,958

Purchases of property and equipment

317

Proceeds from sale of property and equipment

Net cash provided by investing activities

11,858

9,607

Proceeds from the sale of common stock

19,838

Cash paid for issuance costs of stock

1,531

Proceeds from sale of series a convertible preferred stock

7,862

Cash paid for extinguishment-Two Thousand Twenty Six Senior Unsecured Convertible Notes

125,000

Cash paid for extinguishment-Notes Payable

25,000

Proceeds from notes payable issuance-Two Thousand Thirty One Senior Unsecured Convertible Notes

33,250

Cash paid for notes payable debt issuance cost-Two Thousand Thirty One Senior Unsecured Convertible Notes

1,386

Proceeds from notes payable issuance-Notes Payable

108,787

Cash paid for notes payable debt issuance cost-Notes Payable

3,406

Proceeds from purchases under the employee stock purchase plan

587

Receipts for stock issued under the equity incentive plan

-51

258

Net cash provided by financing activities

13,363

845

Net increase (decrease) in cash and cash equivalents

26,552

-9,286

Cash and cash equivalents at beginning of period

25,802

Cash and cash equivalents at end of period

43,068

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow Overview

Change in Cash

$26,552K

Free Cash flow

$1,331K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-09-30

2025-06-30

Net loss

-17,241

Loss on disposal of property and equipment

-95

Stock-based compensation expense

2,852

5,308

Depreciation and amortization

615

1,162

Amortization of debt discount

194

311

Amortization of debt issuance costs

106

Accretion of discount on short-term investments

130

520

Retirement and impairment of property and equipment

409

Loss on extinguishment of debt

-11,339

Accounts receivable

1,116

1,050

Net loss

254

Inventory

-2,940

19,805

Prepaid expenses and other assets

5,248

-698

Accounts payable

-20

328

Accrued clinical and manufacturing liabilities

2,296

-8,083

Accrued payroll and employee related liabilities

2,277

-3,083

Other accrued expenses

2,511

4,541

Net cash used in operating activities

1,331

-19,738

Purchases of short-term investments

6,127

32,087

Maturities and sales of short-term investments

17,956

41,958

Purchases of property and equipment

317

Proceeds from sale of property and equipment

Net cash provided by investing activities

11,858

9,607

Proceeds from the sale of common stock

19,838

Cash paid for issuance costs of stock

1,531

Proceeds from sale of series a convertible preferred stock

7,862

Cash paid for extinguishment-Two Thousand Twenty Six Senior Unsecured Convertible Notes

125,000

Cash paid for extinguishment-Notes Payable

25,000

Proceeds from notes payable issuance-Two Thousand Thirty One Senior Unsecured Convertible Notes

33,250

Cash paid for notes payable debt issuance cost-Two Thousand Thirty One Senior Unsecured Convertible Notes

1,386

Proceeds from notes payable issuance-Notes Payable

108,787

Cash paid for notes payable debt issuance cost-Notes Payable

3,406

Proceeds from purchases under the employee stock purchase plan

587

Receipts for stock issued under the equity incentive plan

-51

258

Net cash provided by financing activities

13,363

845

Net increase (decrease) in cash and cash equivalents

26,552

-9,286

Cash and cash equivalents at beginning of period

25,802

Cash and cash equivalents at end of period

43,068

Time Plot

Show the time plot by selecting a row from the table.